CMMI Renews Contract With Phreesia for Use of PAM

The Centers for Medicare & Medicaid Services (CMS) Innovation Center (CMMI) has renewed its contract with Phreesia for use of the Patient Activation Measure (PAM) through 2029.

Phreesia is a leader in patient intake, outreach, and activation. Its PAM performance measure, which assesses gains in patients’ knowledge, skills, and confidence in managing their own health care, is one of the first patient-reported outcome performance measures used in a CMS alternative payment model.

The PAM is backed by more than 800 peer-reviewed studies and is predictive of health behaviors that are linked to improvements in a patient’s health. When patient activation increases, clinical and mental health outcomes, medication adherence, disease self-management, and treatment satisfaction improve across numerous patient populations and chronic diseases.

Under the new contract, Phreesia will provide access to PAM, training, analysis, and other support to the Kidney Care Choices Model, which aims to improve care and quality of life for Medicare beneficiaries with chronic kidney disease. CMMI also has the option to expand the PAM into additional models, including those focused on other disease states, care settings, or episodes of care.